Orbimed Advisors - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2021$28,713,000
-42.4%
848,503
-29.7%
0.29%
-37.8%
Q1 2021$49,844,000
-10.2%
1,206,886
-5.7%
0.47%
-4.1%
Q4 2020$55,530,000
+109.3%
1,280,086
+106.9%
0.49%
+45.5%
Q3 2020$26,537,000
+137.4%
618,586
+158.6%
0.33%
+112.7%
Q2 2020$11,180,000239,1860.16%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 183,803$9,359,0005.00%
DAFNA Capital Management LLC 229,652$9,852,0003.20%
HealthCor Management, L.P. 1,594,452$68,402,0002.74%
Capital Impact Advisors, LLC 110,000$4,719,0001.40%
Cormorant Asset Management, LP 700,000$30,030,0001.16%
ARK Investment Management 2,495,842$107,072,0000.64%
Millrace Asset Group, Inc. 18,087$776,0000.63%
COOPER CREEK PARTNERS MANAGEMENT LLC 50,532$2,168,0000.54%
Endurant Capital Management LP 34,485$1,479,0000.44%
HealthCor Management, L.P. 200,000$8,580,0000.34%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders